Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP924704.RAexXOF7Qxx2W-GS0WN3HT7HLXbXxQuM8J0ikxb7qhnX0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP924704.RAexXOF7Qxx2W-GS0WN3HT7HLXbXxQuM8J0ikxb7qhnX0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP924704.RAexXOF7Qxx2W-GS0WN3HT7HLXbXxQuM8J0ikxb7qhnX0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP924704.RAexXOF7Qxx2W-GS0WN3HT7HLXbXxQuM8J0ikxb7qhnX0130_provenance.
- NP924704.RAexXOF7Qxx2W-GS0WN3HT7HLXbXxQuM8J0ikxb7qhnX0130_assertion description "[In A375 xenografts, the antitumor effects of sorafenib and MI-319 were additive and associated with the down modulation of Bcl-2 and Bcl-xL, the nuclear translocation of AIF, and increased suppression of tumor angiogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924704.RAexXOF7Qxx2W-GS0WN3HT7HLXbXxQuM8J0ikxb7qhnX0130_provenance.
- NP924704.RAexXOF7Qxx2W-GS0WN3HT7HLXbXxQuM8J0ikxb7qhnX0130_assertion evidence source_evidence_literature NP924704.RAexXOF7Qxx2W-GS0WN3HT7HLXbXxQuM8J0ikxb7qhnX0130_provenance.
- NP924704.RAexXOF7Qxx2W-GS0WN3HT7HLXbXxQuM8J0ikxb7qhnX0130_assertion SIO_000772 21929745 NP924704.RAexXOF7Qxx2W-GS0WN3HT7HLXbXxQuM8J0ikxb7qhnX0130_provenance.
- NP924704.RAexXOF7Qxx2W-GS0WN3HT7HLXbXxQuM8J0ikxb7qhnX0130_assertion wasDerivedFrom befree-2016 NP924704.RAexXOF7Qxx2W-GS0WN3HT7HLXbXxQuM8J0ikxb7qhnX0130_provenance.
- NP924704.RAexXOF7Qxx2W-GS0WN3HT7HLXbXxQuM8J0ikxb7qhnX0130_assertion wasGeneratedBy ECO_0000203 NP924704.RAexXOF7Qxx2W-GS0WN3HT7HLXbXxQuM8J0ikxb7qhnX0130_provenance.
- befree-2016 importedOn "2016-02-19" NP924704.RAexXOF7Qxx2W-GS0WN3HT7HLXbXxQuM8J0ikxb7qhnX0130_provenance.